This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Visser, M R Articles by Verhoef, J Search for Related Content PubMed PubMed Citation Articles by Visser, M R Articles by Verhoef, J

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1991 May; 35(5): 858-868

Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.

M R Visser, M Rozenberg-Arska, H Beumer, I M Hoepelman and J Verhoef

Department of Clinical Microbiology, University Hospital Utrecht, The Netherlands.

ABSTRACT

The in vitro activity of sparfloxacin (AT-4140; RP 64206), a new fluoroquinolone, was compared with those of 10 other agents against 1,222 clinical isolates. Sparfloxacin and ciprofloxacin were the most active quinolones against members of the family Enterobacteriaceae and nonfermenting gram-negative bacilli; sparfloxacin had superior activity against gram-positive cocci in comparison with the activities of ciprofloxacin and the other quinolones tested (norfloxacin, lomefloxacin, and pefloxacin). Among the inhibited strains, several were resistant to the tested beta-lactam antibiotics or to aminoglycosides. The activity of sparfloxacin was not influenced by the medium that was used; lowering of the pH to 5 had a marked effect on the MICs for two strains each of Enterobacter cloacae and Pseudomonas aeruginosa and one strain each of Escherichia coli and Staphylococcus aureus; the MBC of sparfloxacin was within 1 to 2 dilution steps of the MIC for the strains that were tested.

---

Antimicrob Agents Chemother. 1991 May; 35(5): 858-868

This article has been cited by other articles:

• Jones, M. E., Sahm, D. F., Martin, N., Scheuring, S., Heisig, P., Thornsberry, C., Köhrer, K., Schmitz, F.-J. (2000). Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season. Antimicrob. Agents Chemother. 44: 462-466 [Abstract] [Full Text]  
• Orden, J. A., Ruiz-Santa-Quiteria, J. A., García, S., Cid, D., de la Fuente, R. (1999). In Vitro Activities of Cephalosporins and Quinolones against Escherichia coli Strains Isolated from Diarrheic Dairy Calves. Antimicrob. Agents Chemother. 43: 510-513 [Abstract] [Full Text]  
• Jones, M. E., Visser, M. R., Klootwijk, M., Heisig, P., Verhoef, J., Schmitz, F.-J. (1999). Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus Strains. Antimicrob. Agents Chemother. 43: 421-423 [Abstract] [Full Text]  
• Paker, G. E., Graham, J. A., Rauch, A. M., Collins, J. J. (1994). Cefuroxime Axetil in the Treatment of Sinusitis: A Review. Arch Fam Med 3: 165-175 [Abstract]